MC
AIFF

Moors & Cabot’s Firefly Neuroscience AIFF Stock Holding History

Moors & Cabot’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-600
Closed -$4.65K – 897
2023
Q3 		$4.65K Hold
600
– – ﹤0.01% 823
2023
Q2 		$5.49K Hold
600
– – ﹤0.01% 824
2023
Q1 		$5.21K Hold
600
– – ﹤0.01% 846
2022
Q4 		$8.63K Hold
600
– – ﹤0.01% 828
2022
Q3 		$17K Hold
600
– – ﹤0.01% 804
2022
Q2 		$24K Hold
600
– – ﹤0.01% 784
2022
Q1 		$95K Hold
600
– – 0.01% 822
2021
Q4 		$89K Buy
+600
New +$71.7K 0.01% 826

Other funds holding AIFF

Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TWM
Trueblood Wealth Management Lima, Ohio $286M AUM 27.34% 1-Year Est. Return
LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moors & Cabot's AIFF Position: Q4 2023 in Review

Moors & Cabot sold out of Firefly Neuroscience (AIFF) in Q4 2023, closing a stake of 600 shares — an estimated $4.65K sold.

Moors & Cabot first reported a position in AIFF in Q4 2021 and held it in 8 quarters. The position peaked at $95K in Q1 2022. 10 funds tracked by Wall St. Rank hold AIFF as of Q4 2023.

  • Moors & Cabot reported no remaining Firefly Neuroscience position as of Q4 2023 after selling out during the quarter.
  • Moors & Cabot sold 600 Firefly Neuroscience shares in Q4 2023, an estimated $4.65K.
  • Moors & Cabot first reported a position in Firefly Neuroscience in Q4 2021 and held it in 8 quarters.
  • Moors & Cabot's Firefly Neuroscience position peaked at $95K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q4 2023.

Based on Moors & Cabot's 13F filing for Q4 2023, filed 14 Feb 2024.